Tisdag 26 November | 04:33:40 Europe / Stockholm

Prenumeration

Kalender

Tid*
2025-08-27 08:30 Kvartalsrapport 2025-Q2
2025-05-19 - Årsstämma
2025-05-07 08:30 Kvartalsrapport 2025-Q1
2025-02-17 07:30 Bokslutskommuniké 2024
2024-11-06 - Kvartalsrapport 2024-Q3
2024-10-23 - Extra Bolagsstämma 2024
2024-08-26 - Kvartalsrapport 2024-Q2
2024-05-17 - X-dag ordinarie utdelning SEZI 0.00 SEK
2024-05-16 - Årsstämma
2024-05-07 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-11-28 - Extra Bolagsstämma 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-17 - X-dag ordinarie utdelning SEZI 0.00 SEK
2023-05-16 - Årsstämma
2023-04-28 - Kvartalsrapport 2023-Q1
2023-02-20 - Bokslutskommuniké 2022
2023-02-16 - Extra Bolagsstämma 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-07-15 - Kvartalsrapport 2022-Q2
2022-05-19 - X-dag ordinarie utdelning SEZI 0.00 SEK
2022-05-18 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-12 - Kvartalsrapport 2021-Q3
2021-08-27 - Kvartalsrapport 2021-Q2
2021-05-12 - X-dag ordinarie utdelning SEZI 0.00 SEK
2021-05-11 - Årsstämma
2021-05-06 - Kvartalsrapport 2021-Q1
2021-03-05 - Extra Bolagsstämma 2021
2021-02-26 - Bokslutskommuniké 2020
2020-11-06 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-07-02 - Extra Bolagsstämma 2020
2020-05-15 - X-dag ordinarie utdelning SEZI 0.00 SEK
2020-05-14 - Årsstämma
2020-05-08 - Kvartalsrapport 2020-Q1
2020-02-14 - Bokslutskommuniké 2019
2019-11-08 - Kvartalsrapport 2019-Q3
2019-08-22 - Kvartalsrapport 2019-Q2
2019-08-21 - Extra Bolagsstämma 2019
2019-05-09 - X-dag ordinarie utdelning SEZI 0.00 SEK
2019-05-08 - Årsstämma
2019-05-08 - Kvartalsrapport 2019-Q1
2019-02-15 - Bokslutskommuniké 2018
2018-11-08 - Kvartalsrapport 2018-Q3
2018-08-22 - Kvartalsrapport 2018-Q2
2018-05-09 - X-dag ordinarie utdelning SEZI 0.00 SEK
2018-05-08 - Årsstämma
2018-05-08 - Kvartalsrapport 2018-Q1
2018-03-05 - Extra Bolagsstämma 2018
2018-02-16 - Bokslutskommuniké 2017
2017-11-28 - Kvartalsrapport 2017-Q3
2017-09-15 - Extra Bolagsstämma 2017
2017-08-31 - Kvartalsrapport 2017-Q2
2017-05-23 - Årsstämma
2017-05-23 - Kvartalsrapport 2017-Q1
2017-02-16 - Bokslutskommuniké 2016
2016-11-22 - Kvartalsrapport 2016-Q3
2016-08-31 - Kvartalsrapport 2016-Q2
2016-05-17 - Extra Bolagsstämma 2016
2016-04-28 - X-dag ordinarie utdelning SEZI 0.00 SEK
2016-04-27 - Årsstämma
2016-04-27 - Kvartalsrapport 2016-Q1
2016-02-18 - Bokslutskommuniké 2015
2015-11-24 - Kvartalsrapport 2015-Q3
2015-08-26 - Kvartalsrapport 2015-Q2
2015-05-20 - X-dag ordinarie utdelning SEZI 0.00 SEK
2015-05-19 - Årsstämma
2015-05-19 - Kvartalsrapport 2015-Q1
2015-02-25 - Bokslutskommuniké 2014
2014-11-27 - Kvartalsrapport 2014-Q3
2014-11-21 - Extra Bolagsstämma 2014
2014-08-21 - Kvartalsrapport 2014-Q2
2014-05-15 - X-dag ordinarie utdelning SEZI 0.00 SEK
2014-05-14 - Årsstämma
2014-05-14 - Kvartalsrapport 2014-Q1
2014-02-24 - Bokslutskommuniké 2013
2013-11-27 - Kvartalsrapport 2013-Q3
2013-08-20 - Kvartalsrapport 2013-Q2
2013-05-16 - X-dag ordinarie utdelning SEZI 0.00 SEK
2013-05-15 - Årsstämma
2013-05-15 - Kvartalsrapport 2013-Q1
2013-02-28 - Bokslutskommuniké 2012
2013-01-08 - Extra Bolagsstämma 2013
2012-11-21 - Kvartalsrapport 2012-Q3
2012-08-21 - Kvartalsrapport 2012-Q2
2012-05-24 - X-dag ordinarie utdelning SEZI 0.00 SEK
2012-05-23 - Årsstämma
2012-05-23 - Kvartalsrapport 2012-Q1
2012-02-22 - Bokslutskommuniké 2011
2011-11-23 - Kvartalsrapport 2011-Q3
2011-08-23 - Kvartalsrapport 2011-Q2
2011-05-27 - X-dag ordinarie utdelning SEZI 0.00 SEK
2011-05-26 - Årsstämma
2011-05-26 - Kvartalsrapport 2011-Q1
2011-02-16 - Bokslutskommuniké 2010
2010-11-24 - Kvartalsrapport 2010-Q3
2010-05-28 - X-dag ordinarie utdelning SEZI 0.00 SEK
2010-05-27 - Kvartalsrapport 2010-Q1
2009-11-25 - Kvartalsrapport 2009-Q3

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Senzime är verksamt inom medicinteknik. Bolaget utvecklar medicintekniska lösningar som gör det möjligt att följa patienters biokemiska och fysiologiska processer inför, under och efter operation. I portföljen ingår system som används för att automatisera och mäta ämnena glukos och laktat i blod och vävnader. Utöver huvudverksamheten erbjuds även system för att övervaka patienters tillstånd under narkosbehandling. Bolagets huvudkontor ligger i Uppsala.
2024-09-27 13:00:00

The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the “Company”) are hereby convened to an extraordinary general meeting on 23 October 2024 at 10.00 at Advokatfirman Lindahl’s premises on Vaksalagatan 10 in Uppsala.

Notice etc.

Shareholders who wish to participate in the general meeting must:
- be registered in the share register kept by Euroclear Sweden AB on Tuesday 15 October 2024 (the record date), and
- notify his or her intention to attend the general meeting to the Company no later than Friday 18 October 2024, by mail to Advokatfirman Lindahl KB, Att: Michaela Larsson, Box 1203, 751 42 Uppsala stating “general meeting” or by e-mail to michaela.larsson@lindahl.se.

Such notification shall include the shareholder’s name, personal identification number or corporate registration number, address and telephone number, number of shares, details on advisors (no more than two), if any, and, where applicable, details of representatives or proxies.

Nominee-registered shares
Shareholders whose shares are registered in the name of a nominee through a bank or other trustee must, in addition to notify his or her intention to attend the general meeting, register their shares in their own name so that the shareholder is included in the share register kept by Euroclear Sweden on 15 October 2024. Such registration may be temporary (so-called voting rights registration) and shall be requested by shareholders in such time and in accordance with the routines that the nominee determines. Voting rights registrations that have been completed by the nominee no later than 17October 2024 will be considered in the preparation of the share register.

Proxy
Shareholders represented by proxy must submit a dated power of attorney. If the power of attorney is executed by a legal person, a certified copy of the certificate of registration or equivalent must be attached. The power of attorney may not be valid for a period exceeding five years from its issuance. The original power of attorney and certificate of registration should be submitted to the Company by mail at the address mentioned above in due time prior to the general meeting. Alternatively, the original power of attorney and certificate of registration may be brought and presented at the general meeting. The Company provides a power of attorney form at request and on the Company’s website, www.senzime.com.

Number of shares and votes
As of the date of this notice, there are a total of 119,705,523 shares and votes in the Company.

Proposed agenda
1.          Opening of the general meeting and election of chairman of the general meeting
2.          Preparation and approval of the voting list
3.          Election of one or two persons to verify the minutes
4.          Approval of the agenda
5.          Determination as to whether the meeting has been duly convened
6.          Resolution on the approval of the board of directors’ resolution on a directed share issue
7.          Closing of the general meeting

Proposals to resolutions
Item 1 – Election of chairman of the general meeting
The nomination committee proposes that Mattias Prage, lawyer at Advokatfirman Lindahl KB, is elected as chairman of the general meeting or, in his absence, the person otherwise appointed by the board of directors.

Item 6 – Resolution on the approval of the board of directors’ resolution on a directed share issue
On 27 September 2024 the board resolved, subject to approval by the general meeting, on a directed share issue on the terms and conditions set out below (in italics). The board proposes that the general meeting approves the board’s resolution.
Subject to approval by the extraordinary general meeting, the board of directors of Senzime AB (publ), corp. reg. no. 556565-5734 (the “Company”) resolves to carry out a directed issue of maximum 1,104,000 new shares, entailing an increase in the share capital of maximum SEK 138,000. The resolution shall further be governed by the following terms and conditions.

  1. The right to subscribe for new shares shall, with deviation from the shareholders pre-emption rights, belong only to the following persons and in accordance with the specified allocation
NameNumber of shares
Adam Dahlberg700,000
Sorin J. Brull404,000
  1. The reasons for deviating from the shareholders’ preferential rights are that the board of directors has assessed that it would not be doable to in a time- and cost-effective manner successfully carry out rights issue on terms favorable to the Company, at the same time as the Company is in need of capital. The board of directors considers it favorable for the Company and the shareholders to take advantage of the opportunity to inject new capital from strong and reputable investors on attractive terms and in a time and cost-effective manner. The board of directors’ overall assessment is that the reasons for carrying out the new share issue with deviation from the shareholders’ preferential rights overweigh the principal rule that new share issues shall be carried out with preferential rights for existing shareholders, and that a new issue with deviation from the shareholders’ preferential rights is therefore in the interest of the Company and its shareholders.
  2. Subscription of shares shall be made either by payment or on a subscription list not later than October 28, 2024. The board of directors shall have the right to extend the subscription period.
  3. Payment for subscribed shares shall be made not later than October 28, 2024 (same date as the subscription). The board of directors shall have the right to extend the payment period.
  4. The new shares are issued at a price of SEK 6.20 per share. At full subscription, the Company will thus receive SEK 6,844,800 (before issuing costs). The share premium shall be transferred to the unrestricted premium reserve.
  5. The subscription price corresponds to the price used at re-transfer to investors pursuant to the resolution to issueshares in Appendix 3. The board of director’s assessment is that the price is at market terms, since it is based on the market price at the time of the board’s resolution.
  6. The new shares entitle to dividends for the first time on the first record date for dividend that take place after the issue of new shares has been registered with the Swedish Companies Registration Office and been recorded in the share register kept by Euroclear Sweden AB.
  7. The Managing Director is entitled to make any minor changes necessary for the registration of the resolution with the Swedish Companies Registration Office and Euroclear Sweden AB.

Majority requirements
A Resolution in accordance with item 6 above requires, for its validity, support from shareholders holding not less than nine-tenths of both the shares voted and of the shares represented at the general meeting.

Processing of personal data
For information regarding the processing of your personal data, please refer to https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf

The shareholders’ right to information at the general meeting
The board of directors and the CEO shall, up request by any shareholder, and where the board of directors deems that such information may be provided without significant harm to the Company, provide information in respect of any circumstances which may affect the assessment of a matter on the agenda or the Company’s financial position as well as the Company’s relationship to other group companies. Shareholders can submit questions in advance to the Company, to the address Verkstadsgatan 8, 753 23 Uppsala or through e-mail to Slavoljub.Grujicic@senzime.com.

Documents
Documents according to the Swedish Companies Act will be held available at the Company (Verkstadsgatan 8, Uppsala) and at the Company’s website, www.senzime.com, no later than three weeks before the meeting, i.e., no later than 2October 2024. The documents will also be sent, without charge, to shareholders who so request and inform the Company of their postal address.
 
Uppsala in September 2024
Senzime AB (publ)
The board of directors